Xu L - Search Results

1

Extracellular serglycin upregulates the CD44 receptor in an autocrine manner to maintain self-renewal in nasopharyngeal carcinoma cells by reciprocally activating the MAPK/β-catenin axis.

Chu Q, Huang H, Huang T, Cao L, Peng L, Shi S, Zheng L, Xu L, Zhang S, Huang J, Li X, Qian C, Huang B. Chu Q, et al. Among authors: xu l. Cell Death Dis. 2016 Nov 3;7(11):e2456. doi: 10.1038/cddis.2016.287. Cell Death Dis. 2016. PMID: 27809309 Free PMC article.

2

PDZ binding kinase (PBK) is a theranostic target for nasopharyngeal carcinoma: driving tumor growth via ROS signaling and correlating with patient survival.

Wang MY, Lin ZR, Cao Y, Zheng LS, Peng LX, Sun R, Meng DF, Xie P, Yang JP, Cao L, Xu L, Huang BJ, Qian CN. Wang MY, et al. Among authors: xu l. Oncotarget. 2016 May 3;7(18):26604-16. doi: 10.18632/oncotarget.8445. Oncotarget. 2016. PMID: 27049917 Free PMC article.

3

Silencing NKG2D ligand-targeting miRNAs enhances natural killer cell-mediated cytotoxicity in breast cancer.

Shen J, Pan J, Du C, Si W, Yao M, Xu L, Zheng H, Xu M, Chen D, Wang S, Fu P, Fan W. Shen J, et al. Among authors: xu l, xu m. Cell Death Dis. 2017 Apr 6;8(4):e2740. doi: 10.1038/cddis.2017.158. Cell Death Dis. 2017. PMID: 28383557 Free PMC article.

4

The developmental transcription factor IRF6 attenuates ABCG2 gene expression and distinctively reverses stemness phenotype in nasopharyngeal carcinoma.

Xu L, Huang TJ, Hu H, Wang MY, Shi SM, Yang Q, Lin F, Qiang YY, Mei Y, Lang YH, Li CZ, Peng LX, Zheng LS, Huang JL, Li XJ, Zhang SJ, Qian CN, Huang BJ. Xu L, et al. Cancer Lett. 2018 Sep 1;431:230-243. doi: 10.1016/j.canlet.2017.10.016. Epub 2017 Oct 27. Cancer Lett. 2018. PMID: 29111349

5

A comparison of weekly versus 3-weekly cisplatin during concurrent chemoradiotherapy for locoregionally advanced nasopharyngeal carcinoma using intensity modulated radiation therapy: a matched study.

Meng DF, Sun R, Peng LX, Huang YS, Yang Q, Luo DH, Hu WH, Xie FY, Luo W, Zhao C, Guo L, Mai HQ, Chen MY, Xie P, Zheng LS, Yang JP, Mei Y, Qiang YY, Xu L, Li CZ, Huang BJ, Qian CN, Sun R. Meng DF, et al. Among authors: xu l. J Cancer. 2018 Jan 1;9(1):92-99. doi: 10.7150/jca.21357. eCollection 2018. J Cancer. 2018. PMID: 29290773 Free PMC article.

6

miR-27b-3p inhibits proliferation and potentially reverses multi-chemoresistance by targeting CBLB/GRB2 in breast cancer cells.

Chen D, Si W, Shen J, Du C, Lou W, Bao C, Zheng H, Pan J, Zhong G, Xu L, Fu P, Fan W. Chen D, et al. Among authors: xu l. Cell Death Dis. 2018 Feb 7;9(2):188. doi: 10.1038/s41419-017-0211-4. Cell Death Dis. 2018. PMID: 29416005 Free PMC article.

7

Along with its favorable prognostic role, CLCA2 inhibits growth and metastasis of nasopharyngeal carcinoma cells via inhibition of FAK/ERK signaling.

Qiang YY, Li CZ, Sun R, Zheng LS, Peng LX, Yang JP, Meng DF, Lang YH, Mei Y, Xie P, Xu L, Cao Y, Wei WW, Cao L, Hu H, Yang Q, Luo DH, Liang YY, Huang BJ, Qian CN. Qiang YY, et al. Among authors: xu l. J Exp Clin Cancer Res. 2018 Feb 20;37(1):34. doi: 10.1186/s13046-018-0692-8. J Exp Clin Cancer Res. 2018. PMID: 29463274 Free PMC article.

8

Global expression profiling and pathway analysis of mouse mammary tumor reveals strain and stage specific dysregulated pathways in breast cancer progression.

Mei Y, Yang JP, Lang YH, Peng LX, Yang MM, Liu Q, Meng DF, Zheng LS, Qiang YY, Xu L, Li CZ, Wei WW, Niu T, Peng XS, Yang Q, Lin F, Hu H, Xu HF, Huang BJ, Wang LJ, Qian CN. Mei Y, et al. Among authors: xu l, xu hf. Cell Cycle. 2018;17(8):963-973. doi: 10.1080/15384101.2018.1442629. Epub 2018 May 31. Cell Cycle. 2018. PMID: 29712537 Free PMC article.

9

The Upregulation of Trophinin-Associated Protein (TROAP) Predicts a Poor Prognosis in Hepatocellular Carcinoma.

Hu H, Xu L, Chen Y, Luo SJ, Wu YZ, Xu SH, Liu MT, Lin F, Mei Y, Yang Q, Qiang YY, Lin YW, Deng YJ, Lin T, Sha YQ, Huang BJ, Zhang SJ. Hu H, et al. Among authors: xu l, xu sh. J Cancer. 2019 Jan 29;10(4):957-967. doi: 10.7150/jca.26666. eCollection 2019. J Cancer. 2019. PMID: 30854102 Free PMC article.

10

Candidate tumor suppressor gene IRF6 is involved in human breast cancer pathogenesis via modulating PI3K-regulatory subunit PIK3R2 expression.

Xu HF, Huang TJ, Yang Q, Xu L, Lin F, Lang YH, Hu H, Peng LX, Meng DF, Xie YJ, Tan L, Qian CN, Huang BJ. Xu HF, et al. Among authors: xu l. Cancer Manag Res. 2019 Jun 21;11:5557-5572. doi: 10.2147/CMAR.S203060. eCollection 2019. Cancer Manag Res. 2019. PMID: 31417306 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

41,829 results

Search Page

Filters